Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 7 studies | 39% ± 16% |
Insufficient scRNA-seq data for expression of SLC51B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 97% | 441.29 | 86 / 89 | 88% | 15.72 | 795 / 901 |
intestine | 96% | 1208.54 | 931 / 966 | 76% | 13.12 | 401 / 527 |
prostate | 99% | 144.54 | 242 / 245 | 64% | 2.57 | 322 / 502 |
brain | 63% | 40.26 | 1662 / 2642 | 90% | 11.41 | 634 / 705 |
lung | 99% | 192.53 | 574 / 578 | 44% | 4.89 | 503 / 1155 |
liver | 50% | 45.69 | 113 / 226 | 83% | 25.93 | 335 / 406 |
bladder | 95% | 60.14 | 20 / 21 | 31% | 4.12 | 154 / 504 |
uterus | 98% | 108.89 | 167 / 170 | 21% | 2.05 | 96 / 459 |
adrenal gland | 64% | 39.96 | 166 / 258 | 54% | 6.52 | 125 / 230 |
stomach | 46% | 17.27 | 166 / 359 | 68% | 11.19 | 195 / 286 |
esophagus | 78% | 55.22 | 1120 / 1445 | 27% | 3.06 | 50 / 183 |
blood vessel | 100% | 196.36 | 1330 / 1335 | 0% | 0 | 0 / 0 |
ovary | 74% | 42.67 | 134 / 180 | 18% | 1.32 | 78 / 430 |
breast | 59% | 24.98 | 269 / 459 | 15% | 0.66 | 171 / 1118 |
adipose | 69% | 31.50 | 833 / 1204 | 0% | 0 | 0 / 0 |
heart | 47% | 17.74 | 408 / 861 | 0% | 0 | 0 / 0 |
pancreas | 8% | 2.35 | 27 / 328 | 32% | 1.61 | 57 / 178 |
spleen | 40% | 12.49 | 97 / 241 | 0% | 0 | 0 / 0 |
thymus | 23% | 7.66 | 147 / 653 | 3% | 0.11 | 18 / 605 |
skin | 16% | 5.12 | 284 / 1809 | 6% | 0.34 | 28 / 472 |
muscle | 4% | 1.27 | 36 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.27 | 1 / 45 |
peripheral blood | 0% | 0.12 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015721 | Biological process | bile acid and bile salt transport |
GO_0031647 | Biological process | regulation of protein stability |
GO_0090314 | Biological process | positive regulation of protein targeting to membrane |
GO_0032782 | Biological process | bile acid secretion |
GO_0060050 | Biological process | positive regulation of protein glycosylation |
GO_0055085 | Biological process | transmembrane transport |
GO_0070863 | Biological process | positive regulation of protein exit from endoplasmic reticulum |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005215 | Molecular function | transporter activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0015125 | Molecular function | bile acid transmembrane transporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC51B |
Protein name | Organic solute transporter subunit beta (OST-beta) (Solute carrier family 51 subunit beta) |
Synonyms | OSTB |
Description | FUNCTION: Essential component of the Ost-alpha/Ost-beta complex, a heterodimer that acts as the intestinal basolateral transporter responsible for bile acid export from enterocytes into portal blood . Modulates SLC51A glycosylation, membrane trafficking and stability activities . The Ost-alpha/Ost-beta complex efficiently transports the major species of bile acids (taurocholate) . Taurine conjugates are transported more efficiently across the basolateral membrane than glycine-conjugated bile acids (By similarity). Can also transport steroids such as estrone 3-sulfate and dehydroepiandrosterone 3-sulfate, therefore playing a role in the enterohepatic circulation of sterols . Able to transport eicosanoids such as prostaglandin E2 (By similarity). . |
Accessions | ENST00000334287.3 Q86UW2 |